Navigation Links
ExonHit Appoints a New Management Board
Date:3/31/2008

PARIS, March 31 /PRNewswire-FirstCall/ -- ExonHit Therapeutics, a drug and diagnostic discovery company, today announced that Matthew Pando, Ph.D., and John Jaskowiak will join the Management Board on April 1st, 2008. At the same date, Philippe Rousseau will become President of the Management Board, until a new CEO is appointed.

Philippe Rousseau has served as CFO of ExonHit Therapeutics since 2002 and has been a member of its Management Board since 2004. John Jaskowiak, who joined ExonHit in 2006, was recently appointed Head of the Molecular Diagnostics and Genomic Services Unit and Matthew Pando, who joined the Company in 2002, was recently appointed as Head of the Therapeutics Unit.

Laurent Condomine, Chairman of the Supervisory Board, commented: "We are delighted to appoint John Jaskowiak and Matthew Pando to the Management Board, and to appoint Philippe Rousseau as President of the Management Board. The Company continues to advance development of its lead diagnostic test, for Alzheimer's disease, due to be launched in 2009, and of its lead therapeutic compound currently in Phase II, also for Alzheimer's. We are convinced that the combined expertise of Philippe, John and Matthew is essential to enable ExonHit to meet its objective of providing therapeutic and diagnostic solutions in chronic diseases, in an efficient and timely fashion. As previously announced, we have underway an active search for a new CEO for ExonHit Therapeutics."

He added: "The Supervisory Board wishes to take this opportunity to express its gratitude to the founders who have successfully developed many business opportunities, and brought the company to this important stage of development. The three founders of ExonHit will continue to provide their expertise though a consulting arrangement, focusing on ExonHit's collaboration with Allergan."

Philippe Rousseau stated: "People, technologies, patents and money are the key assets to succeed in this fast evolvi
'/>"/>

SOURCE ExonHit Therapeutics SA
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. ExonHit Therapeutics - 2007 Financial Results
2. ExonHit Builds A New Organisation
3. ExonHit and bioMerieux Amend Their Strategic Partnership
4. ExonHit Gets Regulatory Approval to Initiate a Phase 2 Clinical Trial for EHT 0202 in Alzheimers Disease
5. ExonHit Completes a Prototype to Detect Alzheimers Disease From Blood
6. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
7. Pharmasset Appoints Herbert J. Conrad as a Director
8. MacroChem Appoints David P. Luci as New CFO
9. Kosans Board of Directors Appoints Helen S. Kim as Chief Executive Officer
10. RainDance Appoints Becker Chief Commercial Officer
11. Proteon Therapeutics Appoints Experienced Biopharmaceutical Executive, Gregory D. Phelps to its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... July 31, 2014 Sales Horizons, a ... its online sales training course – Mastering the ... sales performance. , Drawn from proven sales training programs ... Mastering the Complex Sale online sales training course is ... who has face-to-face contact with customers, like technical support, ...
(Date:7/30/2014)... 30, 2014 W. R. Grace ... of the REVELERIS® Prep purification system , ... chromatographers, and other researchers to perform both flash ... unit. , With the REVELERIS® Prep purification system, ... chromatography modes with a simple touch of the ...
(Date:7/30/2014)... , July 30, 2014  The Chicago Bears ... American Academy of Dermatology (Academy) in an effort to ... Chicago Bears will host free SPOT me™ skin cancer ... 2 at Soldier Field. SPOT me™ is an ... about the dangers and risks of skin cancer, and ...
(Date:7/30/2014)... Selexis SA , a serial innovation company ... cell line development, announced today new data from the ... at the 10th Annual Cell Line Development and ... 2014 at the Double Tree by Hilton Berkeley Marina ... be presented during an oral presentation: , Title: Genome ...
Breaking Biology Technology:Sales Horizons Offers Mastering the Complex Sale - a Comprehensive, Online Sales Skills Training Course 2Sales Horizons Offers Mastering the Complex Sale - a Comprehensive, Online Sales Skills Training Course 3Grace Launches New REVELERIS® Prep Purification System 2Chicago Bears Join the American Academy of Dermatology in Fight against Skin Cancer 2Chicago Bears Join the American Academy of Dermatology in Fight against Skin Cancer 3Chicago Bears Join the American Academy of Dermatology in Fight against Skin Cancer 4Selexis SA to Present New Data and a Case Study at IBC’s Cell Line Development and Engineering Conference 2Selexis SA to Present New Data and a Case Study at IBC’s Cell Line Development and Engineering Conference 3
... Government ... Order and ... of,advanced technology solutions for homeland and military security, announced,today a ... of airborne biological threats. The AirSentinel,sensors, developed with support from ...
... EPI-Q, Inc., a consulting firm,providing outcomes research ... healthcare industries, announces the addition of,Anthony J. Vita, ... team of clinical,professionals. The specialized background of these ... to offer directly to those clients,seeking to enhance ...
... -,- 3Q07 Net Income Increased 58% Compared to 3Q06 to $11.9 Million, or ... ... Provides Financial Outlook for 2007 and 2008 -, NEW YORK, Nov. 5 ... of,plant-based pharmaceutical and nutraceutical products, today announced,financial results for the third quarter of ...
Cached Biology Technology:ICx Awarded Department of Defense Contract for AirSentinel Monitors 2EPI-Q, Inc. Expands Capabilities with Addition of Anthony Vita, MD, MPH and Peter Herout, PharmD 2American Oriental Bioengineering Reports Third Quarter 2007 Financial Results 2American Oriental Bioengineering Reports Third Quarter 2007 Financial Results 3American Oriental Bioengineering Reports Third Quarter 2007 Financial Results 4American Oriental Bioengineering Reports Third Quarter 2007 Financial Results 5American Oriental Bioengineering Reports Third Quarter 2007 Financial Results 6American Oriental Bioengineering Reports Third Quarter 2007 Financial Results 7American Oriental Bioengineering Reports Third Quarter 2007 Financial Results 8
(Date:7/30/2014)... Monash University Professor Steven Chown has been awarded ... Medal for Excellence in Antarctic Research. , SCAR, ... coordinates high quality international scientific research in the ... Antarctic region in the Earth system. The organisation ... Antarctic Treaty System, responsible for governing the region. ...
(Date:7/30/2014)... iodine-125 (125I) in cancer treatment has been shown ... are critical for neural transmission between the peripheral ... colleagues from Institute of Radiation Medicine, Chinese Academy ... be implanted into rat dorsal root ganglia (DRG) ... with different radioactivity (0, 14.8, 29.6 MBq) were ...
(Date:7/30/2014)... stem cells can develop into a multitude of cells types. ... into the specific types of mature cells that make up ... One key seems to be long chains of sugars that ... group at the University of California, San Diego, has created ... but can be more easily manipulated to direct the process, ...
Breaking Biology News(10 mins):
... Australian medical research has given pregnant women with epilepsy new ... physical birth defects. According to research published in the ... of the American Academy of Neurology, epilepsy experts at ... doses of common epilepsy drug valproate and the increased risk ...
... Medicine and Dentistry has received an award of 94,365 ... Reduction of Animals in Research (NC3Rs), for a pilot study ... cell which could be used in place of the live ... Macrophages are crucial components of the immune system and ...
... 22, 2013   Valid USA continues the expansion ... that it has acquired ScreenCheck North America (SCNA) ... the worldwide exclusive licensee for Polaroid ® identification ... to provide AAMVA compliant Real ID solutions. SCNA also ...
Cached Biology News:Epilepsy drug dosage linked to specific birth defects 2Funding for animal testing alternative 2Valid USA Continues Growth with Acquisition of ScreenCheck North America 2